July 19, 2024

Proton Therapy Market Size Analysis 2022 To 2030

The global proton therapy market size accounted for US$ 452.33 Bn in 2021 and is projected to reach around USD 1.9Bn by 2030, growing at a CAGR of 17.29% from 2022 to 2030.

Proton Therapy Market Size 2022 To 2030

Report Summary

The global proton therapy market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the proton therapy market across the globe.

A comprehensive estimate on the proton therapy market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of proton therapy during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2337

Proton Therapy Market Report Scope 

Report CoverageDetails
Market Size in 2022USD 530.53 million
Market Size by 2030USD 1.9 Billion
Growth Rate from 2022 to 2030CAGR of 17.29%
Largest MarketNorth America
Fastest Growing MarketAsia Pacific
Base Year2021
Forecast Period2022 to 2030
Segments Covered
  • By Indication
  • By Product
  • By Type
  • By Set-Up Systems
  • By Application Type
  • By End-User

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized proton therapy market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Sodium-Ion Batteries Market Size Analysis 2022 To 2030

Proton Therapy Market Players

The report includes the profiles of key proton therapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area are 

  • IBA Worldwide
  • Varian medical systems, Inc
  • HItachi, Ltd
  • Mevion medical systems
  • Sumitomo Heavy Industries, Ltd
  • Optivus Proton Therapy
  • Advanced Oncotherapy plc
  • ProTom International
  • Mitsubishi Corporation
  • ProNova Solutions LLC
  • Sun Nuclear Corporation
  • Provision Healthcare
  • Koninklijke Philips N.V
  • Elekta AB
  • GE Healthcare
  • Best Cyclotron Systems
  • Ray Search Laboratories
  • Permedics

Market Segmentation

By Indication 

  • Breast cancer
  • Prostate cancer
  • CNS cancer
  • Head and Neck cancer
  • Others

By Product

  • Accelerator
  • Beam transport system
  • Bean delivery system
  • Nozzle and image viewers
  • Patient positioning system

By Type

  • Rotating Proton Therapy Systems
  • Non-Rotating Proton Therapy Systems

By Set-Up Systems

  • Multi-Room Systems
  • Compact/ Single-Room Systems

By Application Type

  • Treatment Applications
  • Research Applications

By End-User

  • Hospitals
  • Proton therapy center
  • Others

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Proton Therapy Market 

5.1. COVID-19 Landscape: Proton Therapy Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Proton Therapy Market, By Indication

8.1. Proton Therapy Market, by Indication, 2022-2030

8.1.1. Breast cancer

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Prostate cancer

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. CNS cancer

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Head and Neck cancer

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Proton Therapy Market, By Product

9.1. Proton Therapy Market, by Product, 2022-2030

9.1.1. Tence

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Beam transport system

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Bean delivery system

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Nozzle and image viewers

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Patient positioning system

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Proton Therapy Market, By Type

10.1. Proton Therapy Market, by Type, 2022-2030

10.1.1. Rotating Proton Therapy Systems

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Non-Rotating Proton Therapy Systems

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Proton Therapy Market, By Set-Up Systems

11.1. Proton Therapy Market, by Set-Up Systems, 2022-2030

11.1.1. Multi-Room Systems

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Compact/ Single-Room Systems

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Proton Therapy Market, By Application Type

12.1. Proton Therapy Market, by Application Type, 2022-2030

12.1.1. Treatment Applications

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Research Applications

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Proton Therapy Market, By End-User

13.1. Proton Therapy Market, by End-User, 2022-2030

13.1.1. Hospitals

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Proton therapy center

13.1.2.1. Market Revenue and Forecast (2017-2030)

13.1.3. Others

13.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Proton Therapy Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Indication (2017-2030)

14.1.2. Market Revenue and Forecast, by Product (2017-2030)

14.1.3. Market Revenue and Forecast, by Type (2017-2030)

14.1.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.1.5. Market Revenue and Forecast, by Application Type (2017-2030)

14.1.6. Market Revenue and Forecast, by End-User (2017-2030)

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Indication (2017-2030)

14.1.7.2. Market Revenue and Forecast, by Product (2017-2030)

14.1.7.3. Market Revenue and Forecast, by Type (2017-2030)

14.1.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.1.8. Market Revenue and Forecast, by Application Type (2017-2030)

14.1.8.1. Market Revenue and Forecast, by End-User (2017-2030)

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Indication (2017-2030)

14.1.9.2. Market Revenue and Forecast, by Product (2017-2030)

14.1.9.3. Market Revenue and Forecast, by Type (2017-2030)

14.1.9.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.1.10. Market Revenue and Forecast, by Application Type (2017-2030)

14.1.11. Market Revenue and Forecast, by End-User (2017-2030)

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Indication (2017-2030)

14.2.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.3. Market Revenue and Forecast, by Type (2017-2030)

14.2.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.2.5. Market Revenue and Forecast, by Application Type (2017-2030)

14.2.6. Market Revenue and Forecast, by End-User (2017-2030)

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Indication (2017-2030)

14.2.8.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.8.3. Market Revenue and Forecast, by Type (2017-2030)

14.2.9. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.2.10. Market Revenue and Forecast, by Application Type (2017-2030)

14.2.10.1. Market Revenue and Forecast, by End-User (2017-2030)

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Indication (2017-2030)

14.2.11.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.11.3. Market Revenue and Forecast, by Type (2017-2030)

14.2.12. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.2.13. Market Revenue and Forecast, by Application Type (2017-2030)

14.2.14. Market Revenue and Forecast, by End-User (2017-2030)

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Indication (2017-2030)

14.2.15.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.15.3. Market Revenue and Forecast, by Type (2017-2030)

14.2.15.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.2.16. Market Revenue and Forecast, by Application Type (2017-2030)

14.2.16.1. Market Revenue and Forecast, by End-User (2017-2030)

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Indication (2017-2030)

14.2.17.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.17.3. Market Revenue and Forecast, by Type (2017-2030)

14.2.17.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.2.18. Market Revenue and Forecast, by Application Type (2017-2030)

14.2.18.1. Market Revenue and Forecast, by End-User (2017-2030)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Indication (2017-2030)

14.3.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.3. Market Revenue and Forecast, by Type (2017-2030)

14.3.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.3.5. Market Revenue and Forecast, by Application Type (2017-2030)

14.3.6. Market Revenue and Forecast, by End-User (2017-2030)

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Indication (2017-2030)

14.3.7.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.7.3. Market Revenue and Forecast, by Type (2017-2030)

14.3.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.3.8. Market Revenue and Forecast, by Application Type (2017-2030)

14.3.9. Market Revenue and Forecast, by End-User (2017-2030)

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Indication (2017-2030)

14.3.10.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.10.3. Market Revenue and Forecast, by Type (2017-2030)

14.3.10.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.3.11. Market Revenue and Forecast, by Application Type (2017-2030)

14.3.11.1. Market Revenue and Forecast, by End-User (2017-2030)

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Indication (2017-2030)

14.3.12.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.12.3. Market Revenue and Forecast, by Type (2017-2030)

14.3.12.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.3.12.5. Market Revenue and Forecast, by Application Type (2017-2030)

14.3.12.6. Market Revenue and Forecast, by End-User (2017-2030)

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Indication (2017-2030)

14.3.13.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.13.3. Market Revenue and Forecast, by Type (2017-2030)

14.3.13.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.3.13.5. Market Revenue and Forecast, by Application Type (2017-2030)

14.3.13.6. Market Revenue and Forecast, by End-User (2017-2030)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Indication (2017-2030)

14.4.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.3. Market Revenue and Forecast, by Type (2017-2030)

14.4.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.4.5. Market Revenue and Forecast, by Application Type (2017-2030)

14.4.6. Market Revenue and Forecast, by End-User (2017-2030)

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Indication (2017-2030)

14.4.7.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.7.3. Market Revenue and Forecast, by Type (2017-2030)

14.4.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.4.8. Market Revenue and Forecast, by Application Type (2017-2030)

14.4.9. Market Revenue and Forecast, by End-User (2017-2030)

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Indication (2017-2030)

14.4.10.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.10.3. Market Revenue and Forecast, by Type (2017-2030)

14.4.10.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.4.11. Market Revenue and Forecast, by Application Type (2017-2030)

14.4.12. Market Revenue and Forecast, by End-User (2017-2030)

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Indication (2017-2030)

14.4.13.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.13.3. Market Revenue and Forecast, by Type (2017-2030)

14.4.13.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.4.13.5. Market Revenue and Forecast, by Application Type (2017-2030)

14.4.13.6. Market Revenue and Forecast, by End-User (2017-2030)

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Indication (2017-2030)

14.4.14.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.14.3. Market Revenue and Forecast, by Type (2017-2030)

14.4.14.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.4.14.5. Market Revenue and Forecast, by Application Type (2017-2030)

14.4.14.6. Market Revenue and Forecast, by End-User (2017-2030)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Indication (2017-2030)

14.5.2. Market Revenue and Forecast, by Product (2017-2030)

14.5.3. Market Revenue and Forecast, by Type (2017-2030)

14.5.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.5.5. Market Revenue and Forecast, by Application Type (2017-2030)

14.5.6. Market Revenue and Forecast, by End-User (2017-2030)

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Indication (2017-2030)

14.5.7.2. Market Revenue and Forecast, by Product (2017-2030)

14.5.7.3. Market Revenue and Forecast, by Type (2017-2030)

14.5.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.5.8. Market Revenue and Forecast, by Application Type (2017-2030)

14.5.8.1. Market Revenue and Forecast, by End-User (2017-2030)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Indication (2017-2030)

14.5.9.2. Market Revenue and Forecast, by Product (2017-2030)

14.5.9.3. Market Revenue and Forecast, by Type (2017-2030)

14.5.9.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)

14.5.9.5. Market Revenue and Forecast, by Application Type (2017-2030)

14.5.9.6. Market Revenue and Forecast, by End-User (2017-2030)

Chapter 15. Company Profiles

15.1. IBA Worldwide

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Varian medical systems, Inc

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. HItachi, Ltd

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Mevion medical systems

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Sumitomo Heavy Industries, Ltd

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Optivus Proton Therapy

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Advanced Oncotherapy plc

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. ProTom International

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Mitsubishi Corporation

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. ProNova Solutions LLC

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com